Less than a month after the withdrawal of a widely touted preprint claiming that ivermectin could treat COVID-19, the authors of a meta-analysis that relied heavily on the preprint say they will retract their paper. According to an expression of concern posted yesterday and announced by Paul Sax, the editor of the journal that published … Continue reading Ivermectin meta-analysis to be retracted, revised, say authors
More than three and a half years after being alerted to concerns about the data in a 2015 article, an obstetrics journal has finally retracted the paper, citing a lack of ethics approval for the work. Meanwhile, the co-author of a meta-analysis that relies heavily on the paper has suggested that some critics of the … Continue reading Critics face legal threats as journal takes more than three years to act
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Should journals retract when an author is sent to prison … Continue reading Weekend reads: The ethics committee member who sold grades for cash; how to spot misconduct in clinical trials; biotech cited allegedly altered data in grant application
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Pro-tip: When claiming to use a dataset, make sure it … Continue reading Weekend reads: The unintended consequences of “trust in science”; Biogen, Aduhelm, and JAMA; how to determine author order, part 592
A “systematic error” in a mental health database has led to the retraction of a 2017 paper on how people with psychosis process facial expressions. Joana Grave, a PhD student at the University of Aveiro, in Portugal, and her colleagues published their article, “The effects of perceptual load in processing emotional facial expression in psychotic … Continue reading ‘Please don’t be afraid to talk about your errors and to correct them.’
Talk about missing the trees for the, ahem, forest plots. A researcher is accusing an Elsevier journal of refusing to retract a study that depends in large part on a flawed reference. The paper, “The effect of Acupressure and Reiki application on Patient’s pain and comfort level after laparoscopic cholecystectomy: A randomized controlled trial,” appeared … Continue reading Oh, the gall(stones): A journal should retract a paper on reiki and pain, says a critic
Six months after we reported that journals had slapped expressions of concern on more than three dozen papers by a group of nutrition researchers in Iran, the retractions have started to trickle in. But clock started nearly two years ago, after data sleuths presented journals with questions about the findings in roughly 170 papers by … Continue reading “Yep, pretty slow”: Nutrition researchers lose six papers
One of China’s leading scientists in the fight against COVID-19 failed to disclose ties to a pharmaceutical company in a paper stemming from a clinical trial, Retraction Watch has learned. A co-author on the paper is married to the daughter of that pharmaceutical company’s founder, who herself sits on the firm’s board of directors. Nanshan … Continue reading Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper
A journal has retracted the 2014 report of a clinical trial of a supplement touted as a way to reduce the risk of cardiovascular disease after beginning to suspect that the data were not reliable. The study, “Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled … Continue reading Palmitoleic acid paper pulled for data concerns
A drug company that manufactures a painkiller used for surgery patients has sued an anesthesiology journal along with its editor and publisher and the authors of articles that it says denigrated its product unfairly. In a complaint filed yesterday in U.S. District Court in New Jersey, Pacira Biosciences claims that “In the February 2021 issue … Continue reading Pharma company demands retraction, damages in lawsuit against journal